Health

Results: 4765-4776 of 9325

LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND TO TREAT GERMLINE BRCA-MUTATED HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER AFTER CHEMOTHERAPY

AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Celiac Disease (CD) multiplex microarray

Prime Minister takes part in National HIV Testing Week

BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA

*For research purposes only. Anticipated visual image of LiCellGrow. All features subject to change. (Graphic: Business Wire)

PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality

Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis

The Tobacco and Vapes Bill is set to approve a super-size disposable vape that will create an even greater youth and environmental crisis.

Warning Over Super-Size Disposable Vape in Tobacco and Vapes Bill

Implantica presents the Year-end Report (Q4 2024) on February 14 at 15:00 CET

Local public health services given £200 million boost

Dedicare's Year-end Report 1 January - 31 December 2024: Continued weak progress in the fourth quarter concluded a challenging 2024

PR Newswire associated0

ClariMed Inc. Unveils State-of-the-Art Study Facility in UK, Advancing Human Factors Research Capabilities

Business Wire logo

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile